SNGGDCGCL

Permanent URI for this community

http://localhost:4000/handle/NDLI_IDR/4

Browse

Browsing SNGGDCGCL by Author "Ghosh, Amit"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples
    (Emerging Infectious Diseases, 2025-01-09) Chowdhury, Goutam; Pazhani, Gururaja Perumal; Sarkar, Anirban; Rajendran, Krishnan; Mukhopadhyay, Asish K.; Bhattacharya, Mihir K.; Ghosh, Amit; Ramamurthy, Thandavarayan R
    Carbapenems have been used for many years to treat severe nosocomial Enterobacteriaceae infections. The spread of resistance to these drugs among other bacterial families is an emerging problem worldwide, mostly caused by New Delhi metallo-β-lactamase (NDM-1). We screened for the prevalence of NDM-1–expressing enteric pathogens from hospitalized patients with acute diarrhea in Kolkata, India, and identified 27 Vibrio fluvialis–harboring blaNDM-1 (NDMVF) strains. These isolates were also resistant to all the tested antimicrobial drugs except doxycycline. The large plasmid of V. fluvialis harboring blaNDM-1 could be easily transferred to other enteric pathogens. Genes flanking the blaNDM-1 were found to be identical to the reported sequence from an Escherichia coli isolate. Analyses showed that the V. fluvialis possessing the NDM-VF region belonged to different clones. The pathogenicity of V. fluvialis to humans and its ubiquitous presence in the environment call for constant monitoring of this species for emerging antimicrobial drug resistance.
  • No Thumbnail Available
    Item
    Overview on the New Delhi Metallo- -Lactamase (NDM)-producers
    (2025-01-09) Ghosh, Amit; Sarkar, Anirban; CHOWDHURY, GOUTAM; PAZHANI, GURURAJA PERUMAL; RAMAMURTHY, THANDAVARAYAN
    New -lactamases with ever-broadening substrate specificity are disseminating rapidly all over the world. In the recent years, extent of resistance of human pathogens to -lactam antibiotics is increasing due to the emergence of “new” carbapenemase-producers. New Delhi metallo- -lactamase (NDM) is the latest carbapenemase, detected for the first time during 2008, in bacteria isolated from patients epidemiologically linked to the Indian subcontinent. Apart from carbapenems, NDM-producers are often resistant to other clinically useful antimicrobials such as aminoglycosides and fluoroquinolones. Although the main type of NDM is NDM-1, nine variants have been identified till to date. NDM enzymes have been detected mainly in genetically heterogeneous members of the Enterobacteriaceae family and recently in non-fermenters and Vibrionaceae. The gene blaNDM-1 is located on plasmids of heterogeneous nature of varying sizes and is transferable to a wide range of microbes. Although several methods for the detection of NDM-producers exist, modified Hodge test and the detection of blaNDM-1 by PCR are generally used. Antimicrobials polymyxins (colistin) and glycylcyclines (tigecyclines) show promising activity against NDM-producers in vitro, but there is dispute on their clinical use for safety issues. For preventing the spread of NDM-producers, it is essential to have proper surveillance system in place and for its containment, emphasis should be on research to develop new and safe antimicrobials active against these bugs. In this review, an overview of all these aspects has been presented.